- Home
- MBRX vs BMRA Comparison
MBRX vs BMRA Comparison
Compare MBRX & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBRX
- BMRA
- Stock Information
- Founded
- MBRX 2015
- BMRA 1971
- Country
- MBRX United States
- BMRA United States
- Employees
- MBRX N/A
- BMRA N/A
- Industry
- MBRX Biotechnology: Pharmaceutical Preparations
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- MBRX Health Care
- BMRA Health Care
- Exchange
- MBRX Nasdaq
- BMRA Nasdaq
- Market Cap
- MBRX 5.7M
- BMRA 5.9M
- IPO Year
- MBRX 2016
- BMRA N/A
- Fundamental
- Price
- MBRX $1.88
- BMRA $0.64
- Analyst Decision
- MBRX Strong Buy
- BMRA
- Analyst Count
- MBRX 2
- BMRA 0
- Target Price
- MBRX $24.00
- BMRA N/A
- AVG Volume (30 Days)
- MBRX 62.3K
- BMRA 20.4M
- Earning Date
- MBRX 11-08-2024
- BMRA 01-14-2025
- Dividend Yield
- MBRX N/A
- BMRA N/A
- EPS Growth
- MBRX N/A
- BMRA N/A
- EPS
- MBRX N/A
- BMRA N/A
- Revenue
- MBRX N/A
- BMRA $5,578,000.00
- Revenue This Year
- MBRX N/A
- BMRA N/A
- Revenue Next Year
- MBRX N/A
- BMRA N/A
- P/E Ratio
- MBRX N/A
- BMRA N/A
- Revenue Growth
- MBRX N/A
- BMRA 1.40
- 52 Week Low
- MBRX $0.40
- BMRA $0.24
- 52 Week High
- MBRX $6.24
- BMRA $1.35
- Technical
- Relative Strength Index (RSI)
- MBRX 47.84
- BMRA 73.05
- Support Level
- MBRX $1.65
- BMRA $0.29
- Resistance Level
- MBRX $1.99
- BMRA $1.27
- Average True Range (ATR)
- MBRX 0.20
- BMRA 0.09
- MACD
- MBRX 0.04
- BMRA 0.04
- Stochastic Oscillator
- MBRX 71.79
- BMRA 36.36
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.